Lipase is essential for the study of in vitro release kinetics from organogels

Molecular Pharmaceutics

Volumn 9, Issue 6, 2012, Pages 1803-1811

  Dufresne, Marie Hélène ^a   Marouf, Elaheh ^a   Kränzlin, Yvonne ^a   Gauthier, Marc A ^a   Leroux, Jean Christophe ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

amino acid alkyl ester; antibiotic; cephalosporin; controlled release; implant; in situ forming gels; organogel; safflower oil

Indexed keywords

AMINO ACID; CEFTIOFUR; TRIACYLGLYCEROL LIPASE;

ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG IMPLANT; DRUG RELEASE; GEL; IMPLANT; IN VITRO STUDY; IN VIVO STUDY; PARAMETERS; PRIORITY JOURNAL; RELIABILITY; SCREENING; SLOW DRUG RELEASE;

ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; DRUG DELIVERY SYSTEMS; GELS; KINETICS; LIPASE; SAFFLOWER OIL;

EID: 84862003744     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp3001099     Document Type: Article

References (37)

1. Terech, P.; Weiss, R. G. Low Molecular Mass Gelators of Organic Liquids and the Properties of Their Gels. Chem. Rev. 1997, 97, 3133-3160.
2. van Esch, J. H.; Feringa, B. L. New Functional Materials Based on Self-Assembling Organogels: From Serendipity Towards Design. Angew. Chem., Int. Ed. 2000, 39, 2263-2266. (Pubitemid 30482228)
3. Liu, X. Gelation with Small Molecules: From Formation Mechanism to Nanostructure Architecture. Top. Curr. Chem. 2005, 256, 808-813.
4. Žinic, M.; Vögtle, F.; Fages, F. Cholesterol-Based Gelators. Top. Curr. Chem. 2005, 256, 833-836.
5. Fages, F.; Vögtle, F.; Žinic, M. Systematic Design of Amide- and Urea-Type Gelators with Tailored Properties. Top. Curr. Chem. 2005, 256, 777-784.
6. Araki, K.; Yoshikawa, I. Nucleobase-Containing Gelators. Top. Curr. Chem. 2005, 256, 765-769.
7. Hirst, A.; Smith, D. Dendritic Gelators. Top. Curr. Chem. 2005, 256, 769-772.
8. Murdan, S. Organogels in Drug Delivery. Exp. Opin. Drug Delivery 2005, 2, 489-505. (Pubitemid 41693147)
9. Vintiloiu, A.; Leroux, J.-C. Organogels and Their Use in Drug Delivery - a Review. J. Controlled Release 2008, 125, 179-192.
10. Bonacucina, G.; Cespi, M.; Misici-Falzi, M.; Palmieri, G. F. Colloidal Soft Matter as Drug Delivery System. J. Pharm. Sci. 2009, 98, 1-42.
11. Sahoo, S.; Kumar, N.; Bhattacharya, C.; Sagiri, S. S.; Jain, K.; Pal, K.; Ray, S. S.; Nayak, B. Organogels: Properties and Applications in Drug Delivery. Des. Monomers Polym. 2011, 14, 95-108.
12. Couffin-Hoarau, A.-C.; Motulsky, A.; Delmas, P.; Leroux, J.-C. In Situ-Forming Pharmaceutical Organogels Based on the Self- Assembly of L-Alanine Derivatives. Pharm. Res. 2004, 21, 454-457. (Pubitemid 38338981)
13. Motulsky, A.; Lafleur, M.; Couffin-Hoarau, A.-C.; Hoarau, D.; Boury, F.; Benoit, J.-P.; Leroux, J.-C. Characterization and Biocompatibility of Organogels Based on L-Alanine for Parenteral Drug Delivery Implants. Biomaterials 2005, 26, 6242-6253. (Pubitemid 40826993)
14. Plourde, F.; Motulsky, A.; Couffin-Hoarau, A.-C.; Hoarau, D.; Ong, H.; Leroux, J.-C. First Report on the Efficacy of L-Alanine-Based in Situ-Forming Implants for the Long-Term Parenteral Delivery of Drugs. J. Controlled Release 2005, 108, 433-441. (Pubitemid 41608674)
15. Vintiloiu, A.; Lafleur, M.; Bastiat, G.; Leroux, J.-C. In Situ- Forming Oleogel Implant for Rivastigmine Delivery. Pharm. Res. 2008, 25, 845-852. (Pubitemid 351661832)
16. Bastiat, G.; Leroux, J.-C. Pharmaceutical Organogels Prepared from Aromatic Amino Acid Derivatives. J. Mater. Chem. 2009, 19, 3867-3877.
17. Bastiat, G.; Plourde, F.; Motulsky, A.; Furtos, A.; Dumont, Y.; Quirion, R.; Fuhrmann, G.; Leroux, J.-C. Tyrosine-Based Rivastigmine- Loaded Organogels in the Treatment of Alzheimer's Disease. Biomaterials 2010, 31, 6031-6038.
18. Wang, K.; Jia, Q.; Han, F.; Liu, H.; Li, S. Self-Assembled L-Alanine Derivative Organogel as in Situ Drug Delivery Implant: Characterization, Biodegradability, and Biocompatibility. Drug Dev. Ind. Pharm. 2010, 36, 1511-1521.
19. Guse, C.; Koennings, S.; Maschke, A.; Hacker, M.; Becker, C.; Schreiner, S.; Blunk, T.; Spruss, T.; Goepferich, A. Biocompatibility and Erosion Behavior of Implants Made of Triglycerides and Blends with Cholesterol and Phospholipids. Int. J. Pharm. 2006, 314, 153-160.
20. Koennings, S.; Sapin, A.; Blunk, T.; Menei, P.; Goepferich, A. Towards Controlled Release of BDNF - Manufacturing Strategies for Protein-Loaded Lipid Implants and Biocompatibility Evaluation in the Brain. J. Controlled Release 2007, 119, 163-172. (Pubitemid 46754504)
21. Eckel, R. H. Adipose Tissue Lipoprotein Lipase. In Lipoprotein Lipase; Borensztajn, J., Ed.; Evener Publishers: Chicago, 1987; pp 79-132.
22. Arner, P.; Lithell, H.; Wahrenberg, H.; Brönnegard, M. Expression of Lipoprotein Lipase in Different Human Subcutaneous Adipose Tissue Regions. J. Lipid Res. 1991, 32, 423-9.
23. Schwab, M.; Sax, G.; Schulze, S.; Winter, G. Studies on the Lipase Induced Degradation of Lipid Based Drug Delivery Systems. J. Controlled Release 2009, 140, 27-33.
24. Yang, J.; Koga, Y.; Nakano, H.; Yamane, T. Modifying the Chain-Length Selectivity of the Lipase from Burkholderia cepacia Kwi- 56 through in Vitro Combinatorial Mutagenesis in the Substrate- Binding Site. Protein Eng. Des. Sel. 2002, 15, 147-152. (Pubitemid 34298359)
25. Moore, J. W.; Flanner, H. H. Mathematical Comparison of Dissolution Profiles. Pharm. Technol. 1996, 20, 64-74.
26. O'Hara, T.; Dunne, A.; Butler, J.; Devane, J. A Review of Methods Used to Compare Dissolution Profile Data. Pharm. Sci. Technol. Today 1998, 1, 214-223. (Pubitemid 28387122)
27. Costa, P. An Alternative Method to the Evaluation of Similarity Factor in Dissolution Testing. Int. J. Pharm. 2001, 220, 77-83. (Pubitemid 32476843)
28. Zhang, Y.; Huo, M.; Zhou, J.; Zou, A.; Li, W.; Yao, C.; Xie, S. DDSolver: An Add-in Program for Modeling and Comparison of Drug Dissolution Profiles. AAPS J. 2010, 12, 263-271.
29. Maidina, A.; Belova, A.; Levashov, A.; Klyachko, N. Choice of Temperature for Safflower Oil Hydrolysis Catalyzed by Candida rugosa Lipase. Moscow Univ. Chem. Bull. 2008, 63, 108-110.
30. Domínguez de María, P.; Sánchez-Montero, J. M.; Sinisterra, J. V.; Alcántara, A. R. Understanding Candida rugosa Lipases: An Overview. Biotechnol. Adv. 2006, 24, 180-196.
31. Barter, L. S.; Watson, A. D. J.; Maddison, J. E. Owner Compliance with Short Term Antimicrobial Medication in Dogs. Aust. Vet. J. 1996, 74, 277-280. (Pubitemid 126646747)
32. Sun, Y. C.; Scruggs, D. W.; Peng, Y. X.; Johnson, J. R.; Shukla, A. J. Issues and Challenges in Developing Long-Acting Veterinary Antibiotic Formulations. Adv. Drug Delivery Rev. 2004, 56, 1481-1496. (Pubitemid 38748828)
33. Maddison, J. E. Medication Compliance in Small Animal Practice. Irish Vet. J. 2011, 64, 39-43.
34. Kreye, F.; Siepmann, F.; Willart, J. F.; Descamps, M.; Siepmann, J. Drug Release Mechanisms of Cast Lipid Implants. Eur. J. Pharm. Biopharm. 2011, 78, 394-400.
35. Guse, C.; Koennings, S.; Kreye, F.; Siepmann, F.; Goepferich, A.; Siepmann, J. Drug Release from Lipid-Based Implants: Elucidation of the Underlying Mass Transport Mechanisms. Int. J. Pharm. 2006, 314, 137-144.
36. Appel, B.; Maschke, A.; Weiser, B.; Sarhan, H.; Englert, C.; Angele, P.; Blunk, T.; Göpferich, A. Lipidic Implants for Controlled Release of Bioactive Insulin: Effects on Cartilage Engineered in Vitro. Int. J. Pharm. 2006, 314, 170-178.
37. Shah, V. P.; Tsong, Y.; Sathe, P.; Liu, J.-P. In Vitro Dissolution Profile Comparison - Statistics and Analysis of the Similarity Factor, f2. Pharm. Res. 1998, 15, 889-896. (Pubitemid 28307831)